TCWM
INZY

Total Clarity Wealth Management’s Inozyme Pharma INZY Stock Holding History

Total Clarity Wealth Management’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-30,300
Closed -$169K – 229
2023
Q2 		$169K Buy
+30,300
New +$179K 0.08% 207

Other funds holding INZY

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Total Clarity Wealth Management's INZY Position: Q3 2023 in Review

Total Clarity Wealth Management sold out of Inozyme Pharma (INZY) in Q3 2023, closing a stake of 30,300 shares — an estimated $169K sold.

Total Clarity Wealth Management first reported a position in INZY in Q2 2023 and held it in 1 quarter. The position peaked at $169K in Q2 2023. 77 funds tracked by Wall St. Rank hold INZY as of Q3 2023.

  • Total Clarity Wealth Management reported no remaining Inozyme Pharma position as of Q3 2023 after selling out during the quarter.
  • Total Clarity Wealth Management sold 30,300 Inozyme Pharma shares in Q3 2023, an estimated $169K.
  • Total Clarity Wealth Management first reported a position in Inozyme Pharma in Q2 2023 and held it in 1 quarter.
  • Total Clarity Wealth Management's Inozyme Pharma position peaked at $169K in Q2 2023.
  • 77 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2023.

Based on Total Clarity Wealth Management's 13F filing for Q3 2023, filed 25 Oct 2023.